Page 706 - Basic _ Clinical Pharmacology ( PDFDrive )
P. 706

692     SECTION VII  Endocrine Drugs


                 TABLE 38–3  Drug effects and thyroid function.

                  Drug Effect                              Drugs
                  Change in thyroid hormone synthesis
                     Inhibition of TRH or TSH secretion without induction of   Bexarotene, dopamine, bromocriptine, cabergoline, levodopa, corticosteroids,
                   hypothyroidism or hyperthyroidism       somatostatin, octreotide, metformin, interleukin-6, heroin
                     Inhibition of thyroid hormone synthesis or release   Iodides (including amiodarone), lithium, aminoglutethimide, thioamides, ethionamide,
                   with the induction of hypothyroidism (or occasionally   tyrosine kinase inhibitors (eg, sunitinib, sorafenib, imatinib), HIV protease inhibitors
                   hyperthyroidism)
                  Alteration of thyroid hormone transport and serum total T 3  and T 4  levels, but usually no modification of FT 4  or TSH
                    Increased TBG                          Estrogens, tamoxifen, raloxifene, heroin, methadone, mitotane, 5-fluorouracil,
                                                           perphenazine
                    Decreased TBG                          Androgens, anabolic steroids, glucocorticoids, danazol, l-asparaginase, nicotinic acid
                     Displacement of T 3  and T 4  from TBG with transient   Salicylates, fenclofenac, mefenamic acid, intravenous furosemide, heparin
                   hyperthyroxinemia
                  Alteration of T 4  and T 3  metabolism with modified serum T 3  and T 4  levels but not TSH levels (unless receiving thyroxine replacement therapy)
                     Increased hepatic metabolism, enhanced degradation   Nicardipine, phenytoin, carbamazepine, primidone, phenobarbital, rifampin, rifabutin,
                   of thyroid hormone                      tyrosine kinase inhibitors (eg, sunitinib, sorafenib, imatinib), sertraline, quetiapine
                     Inhibition of 5′-deiodinase with decreased T 3 ,    Iopanoic acid, ipodate, amiodarone, β blockers, corticosteroids, propylthiouracil,
                   increased rT 3                          flavonoids, interleukin-6
                  Other interactions
                    Interference with T 4  absorption from the gut  Oral bisphosphonates, cholestyramine, colesevelam, colestipol, chromium picolinate,
                                                           charcoal, ciprofloxacin, proton pump inhibitors, sucralfate, Kayexalate, raloxifene,
                                                           sevelamer hydrochloride, aluminum hydroxide, ferrous sulfate, calcium carbonate,
                                                           bran/fiber, soy, coffee, orlistat
                     Induction of autoimmune thyroid disease with   Interferon-α, interleukin-2, interferon-β, lithium, amiodarone, tyrosine kinase inhibitors
                   hypothyroidism or hyperthyroidism       (eg, sunitinib, sorafenib, imatinib)
                  Effect of thyroid function on drug effects
                    Anticoagulation                        Lower doses of warfarin required in hyperthyroidism, higher doses in hypothyroidism
                    Glucose control                        Increased hepatic glucose production and glucose intolerance in hyperthyroidism;
                                                           impaired insulin action and glucose disposal in hypothyroidism
                    Cardiac drugs                          Higher doses of digoxin required in hyperthyroidism; lower doses in hypothyroidism
                    Sedatives; analgesics                  Increased sedative and respiratory depressant effects from sedatives and opioids in
                                                           hypothyroidism; converse in hyperthyroidism



                 replacement by conventional laboratory tests. T  should also be   liothyronine has been reported. Any dosage conversions should be
                                                     3
                 avoided in patients with cardiac disease due to significant eleva-  re-titrated based on laboratory and clinical response.
                 tions in peak levels and a greater risk of cardiotoxicity. Using the   The shelf life of synthetic hormone preparations is about
                 more expensive thyroxine and liothyronine fixed-dose combina-  2 years, particularly if they are stored in dark bottles to minimize
                 tion (liotrix) and desiccated thyroid has not been shown to be   spontaneous deiodination. The shelf life of desiccated thyroid is
                 more effective than T  administration alone. T  is best reserved   not known with certainty, but its potency is better preserved if it
                                 4
                                                     3
                 for short-term TSH suppression. Research is ongoing to clarify   is kept dry.
                 whether T  might be more appropriate in patients with a poly-
                         3
                 morphism in the D2 gene or in those who continue to report   ANTITHYROID AGENTS
                 fatigue, weight gain, and mental impairment while on T  alone.
                                                           4
                   The use of desiccated thyroid rather than synthetic prepara-  Reduction of thyroid activity and hormone effects can be
                 tions is never justified, since the disadvantages of protein antige-  accomplished by agents that interfere with the production of
                 nicity, product instability, variable hormone concentrations, and   thyroid hormones, by agents that modify the tissue response to
                 difficulty in laboratory monitoring far outweigh the advantage   thyroid hormones, or by glandular destruction with radiation
                 of lower cost. Significant amounts of T  found in some thyroid   or surgery. Goitrogens are agents that suppress secretion of T
                                                                                                                      3
                                               3
                 extracts may produce significant elevations in  T  levels and   and T  to subnormal levels and thereby increase TSH, which in
                                                        3
                                                                          4
                 toxicity. Exact equi-effective doses have not been determined.   turn produces glandular enlargement (goiter). The antithyroid
                 Approximate equivalence of desiccated thyroid 60 mg (1 gr) to   compounds used clinically include the thioamides, iodides, and
                 80 to 100 mcg of levothyroxine, and approximately 37.5 mcg of   radioactive iodine.
   701   702   703   704   705   706   707   708   709   710   711